老年晚期非小细胞肺癌患者人群治疗策略  

Therapeutic Strategy for Advanced Non-Small Cell Lung Cancer Among the Elderly Population

作　　者：秦全红[1] 章明放[1] QIN Quanhong;ZHANG Mingfang(Department of Pathology,Tianjin First Central Hospital,Tianjin 300192,China)

机构地区：[1]天津市第一中心医院病理科,天津300192

出　　处：《天津科技》2018年第10期84-88,共5页Tianjin Science & Technology

摘　　要：肺癌在所有癌症中死亡率最高,而且老年肺癌患者的数量日益增多,从一个侧面反映了人口老龄化的增势,因而探索老年肺癌患者的标准治疗方案及策略是当务之需。目前对老年非小细胞肺癌患者的化疗疗效尚存在争议,由于老年患者群常常被临床试验排除,虽然多个临床研究提示年龄大小不影响临床获益,但是老年肺癌患者的用药安全性仍不明确。为此,对老年肺癌患者目前的临床治疗和未来的发展前景进行了综述和分析。Lung cancer has the highest mortality rate among all cancers, and the increasing number of elderly lung cancer reflects the increasing population aging in the world. Therefore, the standard treatment plan and strategy for elderly patients with lung cancer need to be established. However, the efficacy of chemotherapy in elderly patients with non-small cell lung cancer is controversial because elderly patients are often excluded from clinical trials. Some clinical trials found that the treatment of third generation anticancer drugs alone was better than the best supportive treatment. This paper reviews the current clinical therapy and future development of elderly patients with lung cancer.

关 键 词：晚期非小细胞肺癌 老年人群 治疗 

分 类 号：R655[医药卫生—外科学]